“…The response of HT is likely to rely on many different factors, among them, the nature of the disease, the number of cells required/administered, their functional performance, and the cells' ability to engraft and survive in the host organ [10,19,20,24,26,27]. One major problem is how to assess the clinical efficacy of HT; we assessed, as other autors, the efficacy mainly based on clinical criteria, which proves more difficult to objectify the analytical data, primarily ammonia levels [6,7,8,9,14,17].…”